AI in GMP: Creating Bounded, Traceable and Governed Workflows

AI is entering GMP spaces through structured workflows that capture prompts, track outputs, secure data sources and document the people responsible for every decision point.

In brief

•  AI can operate in GMP environments through governed systems that use bounded data access, full traceability and clear accountability. 
• Generative and agentic models can support quality activities when prompts, data sources, logs and human oversight are all defined and controlled.

Can AI be GMP?

Can AI operate within the strict quality expectations that control medicine manufacturing?

There is a moment in almost every AI conversation in drug manufacturing when enthusiasm gives way to hesitation. “Can we actually use this?”

Good Manufacturing Practice, the framework that ensures medicines are made safely and consistently, shapes the expectations people bring to conversations about AI. When people ask whether AI can be GMP, they are usually asking whether it can function in the same way as traditional validated automation: deterministic, repeatable, and logically fixed. 

Classic GMP environments were built around systems that produce the same output for the same input, every time. That idea is what standard computerized system validation practice is built on.

AI does not work that way.

Machine learning models are probabilistic by design. Two identical inputs can generate slightly different outputs. Models evolve. Performance shifts as data shifts. It’s not a defect. It is the key characteristic of the technology.

Most discussions of “AI in GMP” stay safely within familiar territory: predictive maintenance, process monitoring and yield optimisation. Using supervised machine learning and multivariate statistical analysis. These are commonplace now, we know how to validate them, how to monitor them, and where their risk boundaries lie.

That is not where our focus needs to be. The real focus should be on the next frontier:

• Large language models drafting deviation reports
• AI reviewing batch records
• AI selecting evidence
• AI recommending disposition decisions
• AI agents orchestrating workflows

Regulatory milestones and publications lag behind AI Technology 

As recent FDA and EMA guidance publications list GenAI and probabilistic models out of scope.

Generative AI and decision-making agentic workflows have moved from theory to deployment in less than two years. And while organisations are still debating potential ROI from AI investments, the real question is simpler and more urgent: what conditions need to be in place for these systems to be GMP?

Good Manufacturing Practice is fundamentally about ensuring that systems affecting product quality are validated for their intended use, operate within defined boundaries, are monitored over time, and remain accountable to human oversight. It requires traceability. It requires change control. It requires reconstruct-ability of decisions.

It does not require determinism. This distinction becomes critical as we move from predictive models to generative and agentic AI.

Generative AI in GMP 

Generative AI makes people uncomfortable because it produces language that looks authoritative. It can draft deviation investigations, propose CAPAs, and suggest equipment maintenance or batch impact assessments.

The concern is not that it is probabilistic. The concern is that it can influence decisions, in simple, human-readable, step-by-step and word-by-word instructions.

So can generative AI be used in a GMP environment?

Yes, but only under strict, explicit constraints.

If a generative model drafts a deviation report, the prompt structure must be defined. The data sources it can access must be bounded. Outputs must be logged and versioned. Human review must be mandatory and documented. The system must clearly establish that the model supports the decision, rather than makes it.

The moment its output is treated as authoritative without oversight, you have stepped outside GMP expectations.

The issue is not variability in wording. It is whether the decision pathway is transparent and defensible.

Agentic AI and Data Selection

The more complex challenge arises when AI begins selecting data, prioritising evidence, or recommending actions.

If a system reviews validated process data and flags potential batch impact, that is manageable; provided the dataset is controlled, the model version is fixed, and outputs are traceable.

If a system dynamically decides which historical deviations are relevant to an investigation, the risk profile increases. Now the model is shaping the evidence base itself.

In GMP terms, this leads to one essential question: can you trace why the AI chose certain data and left out other data? 

This depends on bounded data access, where the AI can only use information from a defined and controlled set of sources, supported by full logging and version control. When those elements are in place, the system can operate within GMP expectations. When they are missing, the issue is a loss of data governance.

If the answer is no, the problem is not artificial intelligence. It is loss of data governance.

Autonomy is not the regulatory issue. Untraceable autonomy is.

It helps to compare this to Advanced Process Control (APC). For years, GMP environments have relied on APC systems that automatically adjust processes within validated limits. They observe conditions, calculate responses, and act without human intervention. They are fully accepted because their models, boundaries, and change controls are defined and governed.

Agentic AI follows a similar structural pattern: it observes, reasons, and acts. The difference is that APC is deterministic while agentic AI is probabilistic and adaptive.

GMP has already accepted controlled autonomy. AI now tests whether probabilistic autonomy can be governed to the same standard.

The Shift in Validation Thinking

You cannot validate a generative model by proving it gives the same answer every time.

You validate its intended use, the limits within which it operates, the data universe it can access, the controls around retraining or updating, the monitoring of performance and drift, and the accountability of the human who signs off.

It is not a workaround. It is classic GMP applied to a new class of tool.

The mistake organisations make is trying to validate the model itself as if it were a fixed algorithm. The correct approach is to validate the governed system around it.

In Conclusion

AI is not GMP.

But AI operating within a defined, controlled, and monitored architecture can absolutely exist inside a GMP environment.